share_log

Quinsam Reports Q1/2022 Results

Quinsam Reports Q1/2022 Results

昆薩姆報告2022年第一季度業績
newsfile ·  2022/05/26 05:55

Toronto, Ontario--(Newsfile Corp. - May 25, 2022) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q1/2022 results, with a net loss of $1.7 million for the quarter ($0.02 per share basic, $0.02 fully diluted) versus net income of $3.6 million ($0.03 per share basic, $0.03 fully diluted) in Q1/2021.

安大略省多倫多-(Newsfile Corp.-2022年5月25日)-Quinsam Capital Corporation(CSE:QCA)(以下簡稱Quinsam或公司)公佈了2022年第一季度業績,該季度淨虧損170萬美元(基本每股0.02美元,完全稀釋後0.02美元),而2021年第一季度淨收益為360萬美元(基本每股0.03美元,完全稀釋後0.03美元)。

"At March 31, 2022, we had net assets of approximately $0.28 per share outstanding," said Roger Dent, CEO. "Our shares continue to trade at a very steep discount of about 2/3 from NAV."

首席執行官羅傑·登特表示:“截至2022年3月31日,我們的淨資產約為每股流通股0.28美元。”“我們的股票交易價格仍較資產淨值有約三分之二的極大折讓。”

Investors can access the Company's full financial statements on sedar.com.

投資者可以在sedar.com上查閲該公司的完整財務報表。

Recent Activity

最近的活動

Small cap market conditions were difficult in Q1/2022 and have remained so to date in Q2/2022.

2022年第一季度小盤股市場狀況艱難,2022年第二季度迄今仍是如此。

Quinsam raised cash in Q1/2022 with net sales of investments of over $900,000. As at March 31, 2022, we had cash of approximately $765,000. Since that time, our largest investee, a cannabis operation in Guelph (Med Compassion Cannabis Farms/251 Massey Road) completed a major refinancing. As a result, we received over $1.5 million in principal, interest and fees from this investee. This has reduced our cannabis exposure by approximately 5% and has resulted in our current cash balance growing to over $2 million.

昆薩姆在2022年第一季度籌集了現金,投資淨銷售額超過90萬美元。截至2022年3月31日,我們擁有約76.5萬美元的現金。從那時起,我們最大的被投資人,Guelph(Med Compensity Cannabis Farm/251 Massey Road)的一家大麻業務完成了一項重大再融資。因此,我們從被投資人那裏獲得了超過150萬美元的本金、利息和手續費。這使我們的大麻風險敞口減少了約5%,並使我們目前的現金餘額增長到200多萬美元。

Given recent market volatility, we have been hesitant about new investments. Also, we are trying to find new investments that allow Quinsam to be a differentiated vehicle in the market.

鑑於最近的市場波動,我們對新投資一直猶豫不決。此外,我們正在努力尋找新的投資,使昆薩姆成為市場上的差異化工具。

We have made one new recent investment, a $200,000 investment in Silver Eagle Mines. This investment will provide us with an equity position of over 10% in this company as well as a substantial warrant position. Silver Eagle has a very interesting organic phosphate opportunity in Nevada. Silver Eagle had a very modest pre-money valuation in the $1 million vicinity. Silver Eagle has filed a non-offering prospectus and we are hoping for a listing prior to year-end. Given the minimal pre-money value, fertilizer prices and agricultural supply concerns, we are optimistic that this investment can perform very well even in current market conditions.

我們最近進行了一項新投資,向銀鷹礦業投資20萬美元。這項投資將為我們提供該公司超過10%的股權以及大量的認股權證頭寸。銀鷹在內華達州有一個非常有趣的有機磷酸鹽機會。銀鷹在融資前的估值非常適中,大約在100萬美元左右。銀鷹已經提交了一份非招股説明書,我們希望在年底之前上市。考慮到最低的前期貨幣價值、化肥價格和對農業供應的擔憂,我們樂觀地認為,即使在當前的市場條件下,這項投資也可以表現得非常好。

Given prevailing market conditions, the timing of future liquidity events is difficult to predict. We are still expecting liquidity events in the coming months from numerous issuers including Gefion, Above Food, Forrest Innovations, Pfane, Zodiac Gold, Electro Metals & Mining and Chargerquest. Given recent market conditions, we are obviously cautious in our outlook. That being said, these companies have all in our opinion made good progress since we invested.

鑑於當前的市場狀況,未來流動性事件的時間很難預測。我們仍預計未來幾個月將有多家發行人發生流動性事件,包括Gefion、Over Food、Forrest Innovation、Pfane、Zodiac Gold、Electro Metals&Mining和Chargerquest。鑑於最近的市場狀況,我們顯然對前景持謹慎態度。話雖如此,在我們看來,自我們投資以來,這些公司都取得了良好的進展。

Issuer Bid

發行人投標

In Q1/2022, Quinsam acquired no shares pursuant to its issuer bid to acquire up to 5,174,605 shares that commenced on August 31, 2021 and will terminate on August 30, 2022. To date, the Company has acquired 3,449,000 shares pursuant to this issuer bid. Quinsam has now repurchased and cancelled over 20 million shares since 2018 pursuant to its issuer bids, resulting in significant NAV per share accretion for remaining shareholders.

在2022年第一季度,Quinsam沒有根據其發行人競標收購至多5,174,605股股票,該競標開始於2021年8月31日,將於2022年8月30日結束。迄今為止,該公司已根據本次發行人投標收購了3,449,000股股票。自2018年以來,Quinsam已根據發行人的出價回購和註銷了超過2000萬股股票,為剩餘股東帶來了顯著的每股資產淨值增值。

About Quinsam Capital Corporation

昆薩姆資本公司簡介

Quinsam is a merchant bank with a focus on "small cap" investments which it believes are undervalued. We do not invest on behalf of third parties or offer investment advice.

Quinsam是一家商業銀行,專注於它認為被低估的“小盤股”投資。我們不代表第三方投資,也不提供投資建議。

Generally, Quinsam does not believe that individual investments are material events. Quinsam may choose to announce certain investments once the company has finished buying its position because we feel that this information helps investors understand our decision making process. Generally, Quinsam does not announce the sale of investments.

總的來説,昆薩姆並不認為個人投資是重大事件。Quinsam可能會選擇在公司購買完其頭寸後宣佈某些投資,因為我們認為這些信息有助於投資者瞭解我們的決策過程。一般來説,昆薩姆不會宣佈出售投資。

For further information contact:

如需進一步信息,請聯繫:

Roger Dent, CEO
(647) 993-5475
roger@quinsamcapital.com

羅傑·登特,首席執行官
(647) 993-5475
郵箱:Roger@QuinsamCapital.com

This press release may contain forward-looking statements relating to anticipated future events, results, circumstances, performance or expectations that are not historical facts but instead represent our beliefs regarding future events, which are inherently uncertain. Forward-looking statements can often, but not always, be identified by forward-looking words such as "anticipate", "believe", "continue", "expect", "goal", "plan", "intend", "estimate", "may", "project", "predict", "potential", "target", and "will" or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance.

本新聞稿可能包含與預期的未來事件、結果、情況、表現或預期有關的前瞻性陳述,這些陳述不是歷史事實,而是代表我們對未來事件的信念,這些事件本身就是不確定的。前瞻性表述常常但不總是可以由前瞻性詞語來識別,如“預期”、“相信”、“繼續”、“預期”、“目標”、“計劃”、“打算”、“估計”、“可能”、“項目”、“預測”、“潛在”、“目標”和“將”,或暗示未來結果的類似詞語,或關於未來事件或業績的其他預期、信念、計劃、目標、假設、意圖或陳述。

By their nature, forward-looking statements require making assumptions which include, among other things, that (i) Quinsam will have sufficient capital to effect its business strategies, (ii) the business strategies will produce the results intended by Quinsam, and (iii) the markets will react and perform in a manner consistent with the business strategies.

就其性質而言,前瞻性陳述要求作出假設,其中包括:(I)Quinsam將有足夠的資本實施其業務戰略,(Ii)業務戰略將產生昆薩姆預期的結果,以及(Iii)市場將以與業務戰略一致的方式作出反應和表現。

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated. Quinsam believes that the expectations reflected in the forward-looking information are reasonable but no assurance can be given that these expectations will prove to be correct. Some risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information in this press release include, but are not limited to: cannabis companies Quinsam has invested in obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization; market and general economic conditions of the cannabis sector or otherwise, interest rates, regulatory and statutory developments, the nature of the Company's investments, the available opportunities and competition for investments, the concentration of our investments in certain industries and sectors, reliance on key personnel, risks affecting investments, management of the growth of the Company, and exchange rate fluctuations. Readers are cautioned that the foregoing list of risks and factors is not exhaustive. Although Quinsam has attempted to identify factors that could cause actual events or results to differ materially from those described in forward-looking information, there may be factors that cause events or results to differ from those intended, anticipated or estimated.

前瞻性信息涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致實際結果或事件與預期的大不相同。昆薩姆認為,前瞻性信息中反映的預期是合理的,但不能保證這些預期將被證明是正確的。可能導致實際結果與本新聞稿中前瞻性信息表述的結果大不相同的一些風險和其他因素包括,但不限於:坤帝科為獲得和維護監管批准而投資的大麻公司,包括獲得和續簽美國州、地方或其他許可證,以及現有保護措施免受美國聯邦或其他起訴的不確定性;監管或政治變化,如適用法律和法規的變化,包括美國州法律合法化;這些因素包括大麻行業的市場和一般經濟狀況、利率、監管和法定發展、公司投資的性質、現有的投資機會和競爭、我們的投資集中在某些行業和部門、對關鍵人員的依賴、影響投資的風險、公司增長的管理以及匯率波動。提醒讀者,前面列出的風險和因素並不是詳盡的。儘管Quinsam試圖確定可能導致實際事件或結果與前瞻性信息中描述的事件或結果大不相同的因素,但可能存在導致事件或結果與預期、預期或估計的事件或結果不同的因素。

The forward-looking information contained herein is provided as at the this date, based upon the opinions and estimates of management and information available to management as at this date. Quinsam does not undertake and specifically disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, unless required by applicable law. Readers are cautioned not to place undue reliance on forward-looking information contained herein.

本文中包含的前瞻性信息是基於對管理層的意見和估計以及管理層在此日期可獲得的信息而於本日期提供的。除適用法律要求外,昆薩姆不承擔任何更新或修改任何前瞻性信息的意圖或義務,無論是由於新信息、未來事件或其他原因。提醒讀者不要過度依賴本文中包含的前瞻性信息。

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICE

不得在美國境內傳播或由任何美國新聞發佈服務機構發佈

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論